Disclosure 0001193125-26-390509-1

SEC FORM 4

$315,194.80

Amylyx Pharmaceuticals, Inc. (AMLX)

Sale of 9,768 shares at $32.2681 per share.

Reporting Person FRATES JAMES M · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001193125-26-390509 · filed 2026-09-14 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Amylyx Pharmaceuticals, Inc. (AMLX)." Disclosed 2026-09-14. https://desqlong.com/cards/0001193125-26-390509-1 (retrieved 2026-09-26).